Replies

Excellent stuff here and i will remember it:
heres a clip”:
...........................
The scientist happened to be
testing the effects of their existing
products on mice that had various
cancers. That’s when she discovered
that one of their dog products
(a dewormer) was 100 percent
effective. This same scientist had
stage 4 brain cancer and, like Joe,
was also given three months to
live. She started taking the dog
dewormer and six weeks later, she
was clear of the cancer.
On January 15, 2017, without
informing the oncologists at MD
Anderson, Joe started taking the
same dewormer while continuing on
the experimental drug.
Every quarter since he began this
treatment, Joe goes to MD Anderson
for a PET scan. May 2017 was three
months after having the PET scan
that lit up like a Christmas tree,
with cancer from “head to tail.” The
May scan came back all clear. There
was no sign of residual tumors, no
recurrent tumors, and no signs of
metastasis.
The oncologists were totally
mystified. Joe suspected it was the
dewormer but decided that it wasn’t
the right time to tell them.
At that point he couldn’t be 100
percent certain whether it was the
dewormer working or the clinical
trial drug they were giving him.
He certainly didn’t want them to
take him off the trial drug if it was
responsible for clearing the tumors.
The clinical trial ended in
September 2017, and he was
scheduled for another PET scan.
That scan was also all clear, without
any sign of cancer.
Since the clinical trial had ended
and getting kicked off was no longer
a concern, he decided it was time to
come clean and tell the oncologists
about using the dewormer. But
before telling them, he wanted to
know how many people were in the
same clinical trial as he was, and
how many of them had responded
positively to the experimental drug.
He was told 1,100 patients were in
the same trial and taking the exact
same medication as Joe. However,
Joe was the only person whose
cancer had gone into remission.
It obviously wasn’t a result of the
experimental drug.
That’s when Joe told them about
taking the dewormer. They were
shocked. But their reply was even
more shocking.
Here is their conversation with
Joe, as he relayed it to me:
“We’ve known for decades that
the anthelmintic class of drugs
could have possible efficacy against
cancer. In fact in the 1980s and
1990s there was an anthelmintic
drug called Levamisole that was
used on colon cancer.”
Joe said, “Doc, if you have known
for decades, why hasn’t more
research been done on it?”
He replied, “Probably because of
money. All of these drugs are far off
patent and nobody is going to spend
a gazillion dollars to repurpose them
for cancer, only to have generic
competition the next day.”
The “Business” of
Cancer In America
Personally, I understand this
situation. I’ve seen similar scenarios
repeated over and over again in
health care.
What I don’t understand, however,
is why the public is always kept in
the dark about potentially lifesaving

The drug you are talking about, was it IVERMECTIN?

The scientist happened to be testing the effects of their existing products on mice that had various cancers. That’s when she discovered that one of their dog products (a dewormer) was 100 percent effective. This same scientist had stage 4 brain cancer and, like Joe, was also given three months to live.

She started taking the dog dewormer and six weeks later, she was clear of the cancer. On January 15, 2017, without informing the oncologists at MD Anderson, Joe started taking the same dewormer while continuing on the experimental drug. Every quarter since he began this treatment, Joe goes to MD Anderson for a PET scan. May 2017 was threemonths after having the PET scan that lit up like a Christmas tree, with cancer from “head to tail.” The May scan came back all clear.
There was no sign of residual tumors, no recurrent tumors, and no signs of metastasis. The oncologists were totally mystified. Joe suspected it was the dewormer but decided that it wasn’tthe right time to tell them. At that point he couldn’t be 100 percent certain whether it was the dewormer working or the clinical trial drug they were giving him. He certainly didn’t want them to take him off the trial drug if it was responsible for clearing the tumors.

The clinical trial ended in September 2017, and he was
scheduled for another PET scan.That scan was also all clear, without any sign of cancer. Since the clinical trial had ended and getting kicked off was no longer a concern, he decided it was time to come clean and tell the oncologists about using the dewormer. But before telling them, he wanted to know how many people were in the same clinical trial as he was, and how many of them had responded positively to the experimental drug. He was told 1,100 patients were in the same trial and taking the exact same medication as Joe. However, Joe was the only person whose cancer had gone into remission. It obviously wasn’t a result of the experimental drug.

That’s when Joe told them about taking the dewormer. They were shocked. But their reply was even more shocking.Here is their conversation with Joe, as he relayed it to me: “We’ve known for decades that the anthelmintic class of drugs could have possible efficacy against cancer. In fact in the 1980s and1990s there was an anthelmintic drug called Levamisole that was used on colon cancer.” Joe said, “Doc, if you have known for decades, why hasn’t more research been done on it?”
He replied, “Probably because of money. All of these drugs are far off patent and nobody is going to spend a gazillion dollars to repurpose them for cancer, only to have generic competition the next day.”

The “Business” of Cancer In America Personally, I understand this situation. I’ve seen similar scenarios repeated over and over again in health care. What I don’t understand, however,
is why the public is always kept in the dark about potentially lifesaving